TOKYO -- Ricoh will acquire U.S.-based biotechnology startup Elixirgen Scientific as early as July in a push to turn messenger RNA technology into a core business, Nikkei has learned.
Business deals
Ricoh jumps into mRNA pharmaceuticals with U.S. startup deal
Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025
An mRNA vaccine candidate for COVID-19 at a lab in Thailand. In vaccines, mRNA pharmaceuticals teach cells to produce certain proteins in order to trigger a protective immune response. © Reuters
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Business deals
